HHS Import Report Gives No Ground: Savings Would Not Exceed 1%
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug Importation Task Force Report suggests a limited, tightly regulated commercial import system is "feasible," but only if policymakers accept minimal savings and possible consequences on drug development. Report does not quantify costs of creating import system, but veto threat is explicit.